Marco Rabusin Selected Research

Marco Rabusin Research Topics

Disease

15	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 12/2009
4	Leukemia 01/2021 - 06/2012
3	Infections 05/2022 - 12/2009
3	Neoplasms (Cancer) 01/2022 - 02/2012
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 06/2009
2	Cytopenia 04/2013 - 12/2008
2	Autoimmune Diseases (Autoimmune Disease) 03/2004 - 01/2004
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 05/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 06/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 06/2021
1	Neutropenia 01/2021
1	Pyomyositis 01/2021
1	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 07/2020
1	COVID-19 01/2020
1	Wiskott-Aldrich Syndrome 01/2020
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2018
1	Neoplasm Metastasis (Metastasis) 04/2015
1	Brain Neoplasms (Brain Tumor) 04/2015
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 04/2015
1	Typical Teratoid Rhabdoid Tumor 04/2015
1	Headache (Headaches) 03/2014
1	Paraganglioma (Paragangliomas) 03/2014
1	Hypertension (High Blood Pressure) 03/2014
1	Hematologic Diseases (Blood Diseases) 02/2014
1	Autoimmune Lymphoproliferative Syndrome 02/2012
1	Bronchiolitis Obliterans Syndrome 12/2011
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2009
1	Evans Syndrome 12/2008
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 12/2008
1	Pure Red-Cell Aplasia 12/2008
1	Thrombotic Thrombocytopenic Purpura 12/2008
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2008
1	Hodgkin Disease (Hodgkin's Disease) 07/2006
1	Hemophilia A (Haemophilia) 07/2004
1	Rheumatoid Arthritis 03/2004
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2004

Drug/Important Bio-Agent (IBA)

2	blinatumomabIBA 01/2022 - 01/2017
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 06/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	Fluconazole (Zonal)FDA LinkGeneric 07/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2018
1	AntibodiesIBA 01/2017
1	epratuzumabIBA 01/2017
1	Human Growth Hormone (Saizen)FDA LinkGeneric 04/2015
1	Genetic Markers (Genetic Marker)IBA 04/2014
1	CatecholaminesIBA 03/2014
1	Glutathione Transferase (Glutathione S-Transferase)IBA 12/2012
1	Messenger RNA (mRNA)IBA 11/2012
1	Dasatinib (BMS 354825)FDA Link 02/2012
1	Immunomodulating AgentsIBA 02/2012
1	2-mercaptopurineIBA 01/2012
1	EnzymesIBA 01/2012
1	Pharmaceutical PreparationsIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	GlucocorticoidsIBA 12/2009
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2009
1	Inosine Triphosphate (ITP)IBA 12/2008
1	polypentamethylenehexamethylenedicarbamateIBA 07/2006
1	SteroidsIBA 01/2004

Therapy/Procedure

9	Hematopoietic Stem Cell Transplantation 01/2019 - 12/2008
8	Therapeutics 01/2022 - 01/2004
7	Drug Therapy (Chemotherapy) 01/2022 - 01/2004
5	Transplantation 04/2013 - 03/2004
3	Stem Cell Transplantation 12/2008 - 01/2004
1	Palliative Care (Palliative Therapy) 01/2022
1	Aftercare (After-Treatment) 01/2020
1	Radiotherapy 04/2015